
REGENXBIO Inc.
USD6.69
+0.17 (+2.61%)
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.73
Prev. Close
$6.52
Day Low
$6.53
Day High
$6.77
52W Low
$5.46
52W High
$16.19
Market Cap
$0.35B
Volume
1.28M
| 6 Mar 2026 |
| Morgan Stanley |
| Overweight |
| Overweight |
| maintain |
| 10 Feb 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Feb 2026 | Goldman Sachs | Neutral | Neutral | maintain |
| 10 Feb 2026 | Chardan Capital | Buy | Buy | maintain |
| 29 Jan 2026 | Chardan Capital | Buy | Buy | maintain |
| 19 Dec 2025 | Stifel | Buy | Buy | maintain |